Search

Your search keyword '"Sanai F."' showing total 104 results

Search Constraints

Start Over You searched for: Author "Sanai F." Remove constraint Author: "Sanai F."
104 results on '"Sanai F."'

Search Results

1. Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories

2. The adjusted prevalence of hepatitis delta virus (HDV) in 25 countries and territories

3. Global multi-stakeholder endorsement of the MAFLD definition

6. Biliary ascariasis: Report of a complicated case and literature review

7. The present and future disease burden of hepatitis C virus infections with todayʼs treatment paradigm – volume 3

8. Historical epidemiology of hepatitis C virus (HCV) in select countries – volume 3

9. Strategies to manage hepatitis C virus infection disease burden – volume 3

10. The case for simplifying and using absolute targets for viral hepatitis elimination goals

11. Higher body mass index is associated with increased lung stiffness and less airway obstruction in individuals with asthma and fixed airflow obstruction.

12. The case for simplifying and using absolute targets for viral hepatitis elimination goals.

22. Reduced lung elastic recoil and fixed airflow obstruction in asthma

30. Association of single nucleotide polymorphisms in micro RNAs with susceptibility to hepatitis B virus infection and HBV-related liver complications: A study in a Saudi Arabian population.

31. Shortening overall treatment to 12 weeks of SIMEPREVIR plus pegylated-interferon/ribavirin according to early virologic response in treatment-naïve patients with chronic HCV genotype 4 infection and mild-to-moderate fibrosis

38. Global multi-stakeholder endorsement of the MAFLD definition

39. The case for simplifying and using absolute targets for viral hepatitis elimination goals

40. Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response

42. Clinical and patient-reported outcomes in patients with chronic hepatitis B and C and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia, Turkey and Egypt.

43. Multicenter validation of FIB-6 as a novel machine learning non-invasive score to rule out liver cirrhosis in biopsy-proven MAFLD.

44. Hepatitis B virus infection in Saudi Arabia and the UAE: Public health challenges and their remedial measures.

45. Evaluation of a Continuous Blood Glucose Monitor: A Novel and Non-Invasive Wearable Using Bioimpedance Technology.

46. Development and multicenter validation of FIB-6: A novel, machine learning, simple bedside score to rule out liver cirrhosis and compensated advanced chronic liver disease in patients with chronic hepatitis C.

47. Within-session variability as quality control for oscillometry in health and disease.

48. Incidence, Prevalence, and Clinical Epidemiology of Inflammatory Bowel Disease in the Arab World: A Systematic Review and Meta-Analysis.

49. Revealing Hepatitis B Virus as a Silent Killer: A Call-to-Action for Saudi Arabia.

50. Higher body mass index is associated with increased lung stiffness and less airway obstruction in individuals with asthma and fixed airflow obstruction.

Catalog

Books, media, physical & digital resources